Abstracts

Quality Of Life Assessment in Head and Neck Cancer Patients Undergoing Radiation Therapy in a Tertiary Referral University Hospital

Abstract

Introduction: There is considerable post-treatment morbidity in survivors of head and neck cancer (HNC) despite improved survival following multimodality therapy. Assessment of health-related quality of life (HR-QoL) gives valuable information about functional and psychosocial sequelae of radiation therapy (RT), especially in less-studied populations like South Asians.

Methodology: A prospective observational study was conducted between August 2023 and December 2024, including biopsy-proven HNC patients receiving curative-intent RT (definitive or adjuvant). The EORTC QLQ-HN35 questionnaire (Urdu/English, interviewer-assisted) was administered at baseline and 12 ± 2 weeks post-RT. Mean ± SD were calculated for each domain. Pre- and post-treatment differences were analyzed using paired t-tests, while multivariate analysis (GLM-MANOVA) identified factors associated with HR-QoL outcomes.

Results: Fifty-six patients (mean age, 49 ± 13 years; male sex, 78.6%) were included in the analysis. There was a marked deterioration of xerostomia (p = 0.004), pain (p = 0.011) and taste/smell (p = 0.018), whereas social contacts (p = 0.048) and sexuality (p < 0.001) improved after therapy. Tumor site (p < 0.001), histological subtype (p < 0.001) and marital status (p < 0.001) were the main HR-QoL predictors detected. Both oropharyngeal/hypopharyngeal locations were related to more post-treatment pain and social-eating problems.

Conclusion: Within three months after curative-intent RT, HNC patients showed worsening of xerostomia, pain, and sensory loss, with improvement in social contact and sexuality. Tumor site, histopathology, and marital status were key predictors of HR-QoL, demonstrating anatomical, biological, and psychosocial influences. Targeted follow-up and supportive care are important for future studies integrating patient-reported and objective outcomes to personalize survivorship care.

Conflict of interests: The authors declare no conflict of interest.

Funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

License: ©️ Author(s) 2026. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, and unrestricted adaptation and reuse, including for commercial purposes, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.